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ABSTRACT 
Acute Otitis Media (AOM) represents one of the most commonly diagnosed 
conditions in pediatric primary care. Recent studies have questioned the practice of 
routine follow-up for all children diagnosed with AOM. The purpose of this study was to 
determine if the parental report of presence or absence of infection at the follow-up visit 
agreed with the exam performed by the health care provider. A convenience sample of 
parents of patients diagnosed with AOM at the Pediatric Clinic of Hill Air Force Base 
was used. Quantitative data were gathered and analyzed. The results showed that parents 
were accurate in their perception of persistent infection. The results of this study suggest 
that altering the current practice patterns by eliminating the routine follow-up visit for all 
patients diagnosed with AOM may be done without compromising patient health care 
outcomes. 
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CHAPTER I 
INTRODUCTION 
Otitis media is one of the most commonly diagnosed conditions in pediatric 
primary care. It is estimated that at least 30% of the pediatric providers time is spent in 
diagnosing and managing acute otitis media (AOM), involving 25 to 30 million visits 
annually (Adderson, 1998; Bluestone, 1989; Fergie & Purcell, 1998; Hathaway, Katz, 
Dershewitz, & Marx, 1994; Klein, 1994). In addition to this condition occupying a large 
amount of the provider's time, the treatment provided to the patient most often involves 
antibiotic therapy. Approximately 30 million prescriptions are written annually for 
antibiotics in treatment of AOM, adding to the increasing problem of antibiotic 
resistance (Bluestone, 1989; Conrad, 1998; Paradise, 1995). 
The current standard treatment regime for AOM is to treat the patient with a 5- to 
10- day course of antibiotics and then ask the patient to return for an evaluation 2 to 3 
weeks after the diagnosis to determine if the infection has cleared (Altemeier, 1998; 
Bluestone, 1989; Paradise, 1995). This pattern of routine follow-up has come under 
scrutiny lately due to the increased understanding of the normal course of resolution of an 
AOM. The effusion accompanying an AOM may persist for several months after the 
initial infection has cleared (Altemeier, 1998; Bluestone, 1989; Daly, 1991; Fergie & 
Purcell, 1998; Hathaway, et al., 1994). Routine examination of all patients 2 to 3 weeks 
after diagnosis may undoubtedly yield many who have either resolving AOM or a 
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persistent effusion as a consequence of a resolved ADM. Many providers will still 
choose to treat (with another course of antibiotics) those patients who show evidence of 
the above conditions, believing this represents persistent infection, and not understanding 
that complete resolution will take longer than 2 to 3 weeks. 
Due to the increasing problems of antibiotic resistance, as well as the enormous 
costs associated with the treatment of ADM, it is imperative that pediatric primary care 
providers identify ways in which antibiotic use and costs could be reduced without any 
serious sequelae to the patient. Elimination of unnecessary visits and courses of 
antibiotics will decrease costs and limit the progression of antibiotic resistance. 
Statement of the Problem 
Proper diagnosis and treatment of ADM involves educating parents regarding the 
signs and symptoms of ADM, evaluation of the tympanic membrane and middle ear by a 
health care provider, and treatment of the infection with appropriate therapy. In addition 
to a visit for diagnosis and treatment, most practitioners believe that the child must have a 
visit after completing the treatment to assess whether or not the infection has cleared. 
The timing of this posttreatment evaluation visit varies by provider but is generally 
scheduled 2 to 3 weeks after completing the antibiotic (Hathaway et aI., 1994; Schwartz 
et aI., 1987). The findings at the follow-up exam dictate whether or not the child is 
placed on another course of antibiotic therapy. The problem occurs when the child has an 
infection that is clearing, but the follow-up visit shows evidence of effusion still present. 
Studies have shown that the effusion resulting from an ADM may take up to 3 months to 
clear completely. If an asymptomatic child is seen soon after antibiotic treatment has 
been completed, he or she may be unnecessarily treated for an unresolved or persistent 
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AOM when in reality the effusion is just clearing on its own natural course. 
The magnitude of this problem is overwhelming. Considering approximately one 
third of all pediatric visits made to a health care provider are for otitis media and that all 
children diagnosed with AOM are instructed to return for follow-up, many available 
appointments will be taken up by unnecessary follow-up visits. The visit cost alone is a 
phenomenal expense, with increased expenses being caused by additional antibiotics 
(potentially unnecessary), lost wages, vacation and sick leave for parents taking the child 
to appointments, lost time from school for the child, unnecessary invasive procedures, as 
well as the larger, global issue of increased antibiotic resistance (from repeated courses of 
antibiotic therapy with stronger antibiotics). 
The research surrounding the question of necessity of post treatment follow-up 
has been limited. Only two studies have looked at this issue. Schwartz (1987) concluded 
that the posttreatment evaluation could be delayed until 30 days after completion of 
treatment, thus avoiding misdiagnosis of a resolving AOM as a persistent or recurrent 
infection. Hathaway et al. (1994) looked at the correlation between parental report of 
signs and symptoms of infection with the objective evaluation by a health care provider. 
This study found correlation between parental report and actual presence or absence of 
infection to be extremely high, suggesting that parents know whether or not their child is 
better and could possibly be told to bring the child back in for follow-up only if he or she 
appears to have an unresolved AOM. 
Purpose of the Thesis 
Currently, only two research studies have specifically focused on the necessity of 
routine follow-up visits at 2 to 3 weeks postdiagnosis of an AOM. In addition, there have 
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been no studies of this type in a select population of military beneficiaries who bear no 
direct costs for their care when obtained in a military treatment facility. Therefore, the 
purpose of this study was to determine if the parental report of symptoms of AOM and 
assessment of presence of infection at the follow-up visit agreed with the actual presence 
or absence of persistent acute otitis media (P AOM) as determined by an objective exam 
from the health care provider. Specifically, if the parent is able to correctly identify signs 
and symptoms of PAOM, can the routine follow-up visit be eliminated for the majority of 
patients diagnosed with AOM? 
Answers to the above questions will provide the primary care provider with the 
information necessary to implement a change in the current standard of care for patients 
diagnosed with AOM. The current literature supports the ability of the parent to identify 
the presence or absence of infection. Extensive research regarding the natural history of 
AOM also reveals that effusions may last up to 3 months and that 90% resolve 
spontaneously without additional antibiotic treatment. 
The information gained from this study will be used as a foundation for future 
research into this subject in other settings as well as a basis for a change in the current 
standard of practice of AOM follow-up care. Based on the results of this study, one of 
the following options could be chosen: (1) The current practice of follow-up evaluations 
for all patients diagnosed with AOM will be validated as necessary and could be 
continued. (2) A policy change could be implemented, stating that when a child is 
diagnosed with AOM, the signs and symptoms of AOM will be reviewed with the 
caregiver, who will then be instructed to bring the child in for follow-up only if they feel 
the infection has not resolved. 
CHAPTER II 
REVIEW OF THE LITERATURE 
Impact and Incidence of AOM 
Otitis media is one of the most commonly diagnosed conditions in children, 
accounting for more than one third of all visits to the primary care provider (Adderson, 
1998; Bluestone, 1989; Hathaway et al., 1994). The number of visits for this condition 
has doubled from 1975 to 1990, leading to a 200% increase in the diagnosis of AOM 
(Chartrand & Pong, 1998; McCraig & Hughes, 1995; Rosenfeld, 1996). McCraig (1995), 
Chartrand and Pong (1998) all agree that the increase in incidence can be~direct1y 
attributed to the increasing use of day care facilities, with over 11 million children in day 
care in the United States. 
Research studies have shown that the incidence of AOM is greater in children 
who are under age 3, attend day care centers (especially in the larger facilities), are 
exposed to tobacco smoke, have a family history of infection, are Caucasian, male, bottle 
fed and are put to bed with a bottle (Adderson, 1998; Chartrand & Pong, 1998; Daly, 
1991; Hathaway et al., 1994; Kempthorne & Giebink, 1991). AOM is uncommon in 
infants under 6 months as well as in infants who are breastfed due to the protective effect 
of the maternal antibodies (Adderson, 1998; Daly, 1991; Kligman, 1992), 
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Treatment Variations 
Historically, ADM was not treated with antibiotics and 80% of the cases resolved 
on their own (Kempthorne & Giebink, 1991). Despite this apparent success in resolution 
without treatment, 20% of patients developed complications, such as meningitis or 
mastoiditis (Kempthorne & Giebink, 1991). With the advent of antibiotic treatment for 
ADM, most of the complications were no longer seen (Bluestone, 1989). 
The treatment of a patient with AOM depends on more than just the presence of 
an infection at a specific point in time. The provider must take into account the age of 
the patient, whether or not there has been a history of other infections, and what treatment 
has worked in the past. The provider then uses this information, along with his or her 
own experience and personal preferences to determine the appropriate treatment. There 
are several philosophies about proper treatment, with most variation originating from the 
country of the provider. 
The most common first line antibiotic choice is amoxicillin (Bluestone, 1989; 
Kempthorne & Giebink, 1991; Klein, 1994; Kligman, 1992). It is effective against the 
four most common bacterial pathogens: strep pneumonia, H. influenza, M. catarrhalis, 
and group A streptococcus; is inexpensive and has relatively few side effects (Bluestone, 
1989; Kempthorne & Giebink, 1991). Second line antibiotic recommendations are not as 
straightforward. The provider's personal experience and the resistance patterns of the 
local area provide the determining factors in making the appropriate choice, but an 
antibiotic effective against beta(b )-lactamase producing bacteria is usually necessary 
(Bluestone, 1989). 
Treatment of ADM in the United States has traditionally been accomplished by 
administration of a broad spectrum antibiotic immediately after diagnosis, and continued 
for 10- to 14- days (Conrad, 1998; Kempthome & Giebink, 1991). Recently, American 
and European researchers have found that shorter duration of treatment may be equally 
effective as the typical 10- to 14- day courses (Dowell et al., 1998; Kempthome & 
Giebink, 1991). Common practice in many countries outside of the United States is to 
treat the infection with comfort measures and to avoid the use of antibiotics altogether 
(Bollag & Bollag-Albrecht, 1991; Chartrand & Pong, 1998; Conrad, 1998; Dowell et aI., 
1998; Kligman, 1992). Several studies have examined the effectiveness of antibiotic 
versus placebo in treating AOM and have found only a small difference in the resolution 
rate and treatment failure (Chartrand & Pong, 1998; Paradise, 1995; Rosenfeld, 1995; 
Rosenfeld, 1996). Burke et aI. suggest that the routine use of antibiotics is associated 
with incomplete resolution of AOM and may actually add to the sequele of middle ear 
effusion (1991). Other researchers have also asserted that due to the fact that antibiotics 
are only partially effective and many infections resolve on their own, antibiotic therapy 
may not always be necessary and should be reserved for the more severe cases (Canafax 
& Giebink, 1991; Rosenfeld, 1996). The consensus of most experts is that despite a 
bacterial etiology not always being identifiable, antibiotic treatment is necessary to avoid 
suppurative complications (Kligman, 1992; Rosenfeld, 1996). 
Direct and Indirect Costs of Treatment 
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The direct costs of treating an AOM consist of the cost of the initial and follow-up 
office visits, prescription medications, consultation visits to other providers, treatment of 
complications and if necessary, surgical treatment. These costs have been estimated to be 
between three and four million dollars annually for the medical and surgical treatment 
necessary (Adderson, 1998; Daly, 1991; Fergie & Purcell, 1998; Kligman, 1992; 
Schwartz, et aI., 1987). With the trend towards using the more expensive antibiotics 
instead of the less expensive amoxicillin as first line therapy, there is a potential for the 
costs to increase even further. 
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The indirect costs associated with AOM are difficult to quantify. They include 
such costs as lost time from school for the child, lost work time for the parents, the 
increase in antibiotic resistance necessitating stronger, more expensive antibiotic therapy, 
and the emotional toll on the child and family resulting from clinic visits and invasive 
procedures. One analysis of these direct and indirect costs estimated them at $406 per 
episode and $2174 per episode for those cases involving surgical procedures (Fergie and 
Purcell, 1998). 
Prevention of AOM has been suggested as one way to attempt to reduce these 
costs. Adderson states that altering environmental factors, utilizing immunizations, and 
selectively using antibiotic prophylaxis could result in a 25% reduction in AOM episodes 
with a cost savings of over one billion dollars annually (1998). Delaying initial antibiotic 
treatment and nontreatment of asymptomatic effusions after AOM are other methods 
suggested to reduce costs and assist in preventing the rising rate of antibiotic resistance 
(Conrad, 1998; Dowell et al., 1998). 
The Increasing Problem of Antibiotic Resistance 
Approximately 30 million prescriptions are written each year for the treatment of 
otitis media (Bluestone, 1989). With studies showing that up to 80% of the infections 
would resolve on their own without antibiotic treatment, one could easily argue that many 
of these prescriptions are written, and thus taken, unnecessarily. Chartrand and Pong 
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state that such over diagnosis and subsequent over use of antibiotics is the primary reason 
for the increase in antibiotic resistance we are seeing today (1998). In addition to the 
over diagnosis and over treatment of AOM, many patients do not take the medications as 
ordered or quit taking them early, thus offering a prime environment for the development 
of resistant bacteria. 
B-Iactamase production is one method bacteria have developed to increase their 
resistance to antibiotics. A significant increase in production of this enzyme has occurred 
in the last 10 years, with 40 to 50% of H. influenza strains and 80 to 100 % of M. 
catarrhalis all producing b-Iactamase (Block, 1998; Klein, 1994; Kligman, 1992; 
Rosenfeld, 1996). Amoxicillin is still an effective first line medication despite the 
increase in b-Iactamase production. However, when Amoxicillin is not effective, second 
and third line medications that are effective against b-Iactamase producing organisms 
must be used. These medications are much more expensive and may be adding to the 
increasing prevalence of resistant bacteria. 
Penicillin resistant S. pneumoniae is also on the rise, with up to 40% being 
resistant (Adderson, 1998). With penicillin resistant S. pneumonia, an entirely different 
mechanism of resistance is at work. In this situation, the presence of a b-Iactamase 
producing enzyme in an antibiotic is not important, but necessitates the use of a stronger 
antibiotic that is effective against the alteration in penicillin-binding proteins. (Conrad, 
1998; Paradise, 1995). This situation is much more concerning than b-Iactamase 
resistance, as there are currently no oral antimicrobials effective against these types of 
organisms (Conrad, 1998). 
The pattern of utilizing second or third line medications to treat an initial episode 
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of AOM may actually increase the incidence of treatment failure as well as add to the 
problem of increasing antibiotic resistance (Chartrand & Pong, 1998; Rosenfeld, 1996). 
Penicillin resistant S. pneumoniae, which can cause persistent AOM, is also increasing, 
especially among younger children who attend large group day care facilities and 
children who have recently been treated with a beta-Iactam antibiotic (Rosenfeld, 1996). 
An overuse of all antibiotics, especially in the closed environment of day care centers, 
contributes to the increase in bacterial resistance (Chartrand & Pong, 1998, McCraig & 
Hughes, 1995; Paradise, 1995). Ultimately, the benefit to the patient must be examined 
with respect to the global public health risk of increasingly resistant bacteria. 
Diagnostic CriterialUse of Tools to Confirm Diagnosis 
Complete visualization of the tympanic membrane (TM) is necessary to 
accurately determine the presence of infection. In addition to making an assessment of 
the color and position of the TM, the provider must also determine the mobility of the 
TM. 
One of the problems surrounding making an accurate diagnosis of AOM is the 
subjective nature of the assessment (Bollag & Bollag-Albrecht, 1991). Providers use a 
visual examination of the TM, taking into account color, presence of fluid, and mobility 
of the TM along with the symptoms reported by the parents and patients. There is a high 
degree of provider variability in making the assessments and subsequent diagnosis, thus 
making the diagnosis of AOM questionable at times (Bollag & Bollag-Albrecht, 1991; 
Dowell et aI., 1998). 
A pneumatic otoscope is an essential tool for the accurate diagnosis of AOM. 
Color alone is not a sufficient measure of assessment as a reddened TM may be caused 
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by crying or fever and not by the presence of infection (Altemeier, 1998; Bluestone, 
1989; Kempthorne & Giebink, 1991), When pnuematic otoscopy is used, position, color, 
degree of translucency, and mobility all must be assessed (Dowell et aI., 1998; Klein, 
1994), Pneumatic otoscopy requires the use of an otoscope with an airtight seal to 
observe for movement of the TM when air is insufflated into the canal. By observing the 
presence or absence of movement, the provider can make an assessment regarding the 
presence of fluid in the middle ear. This information will be used, along with other 
subjective and objective information, to make the diagnosis of AOM (Bluestone, 1989; 
Kempthorne & Giebink, 1991; Klein, 1994; Paradise, 1995). Pneumatic otoscopy adds a 
measure of objectivity to an otherwise very subjective and symptom dependent diagnosis. 
Other tools available to assess for presence of fluid in the middle ear include 
tympanometer, acoustic reflectometer, and tympanocentesis. Both the tympanometer and 
the acoustic reflectometer offer more sophisticated assessment of the middle ear status, 
but standards have not been set for their interpretation (Kempthorne & Giebink, 1991). 
Tympanocentesis is the only method that determines the true status of the middle ear, but 
most pediatric providers are not skilled in the technique, and it is considered extremely 
invasive for all but the most severe or nonresponsive cases of AOM (Kempthorne & 
Giebink, 1991). 
Normal Etiology of an AOM 
Otitis media normally begins when bacterial or viral organisms present in the 
nasopharynx migrate to the middle ear, replicate, and cause edema and eustachian tube 
malfunction (Adderson, 1998). Often times, this is preceded or accompanied by other 
upper respiratory infections. Several researchers have theorized that AOM is part of a 
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myriad of middle ear pathology that can range from asymptomatic disease to acute 
infection to chronic effusion (Kempthome & Giebink, 1991). Each part of the spectrum 
has different manifestations that need to be addressed and treated differently. As a single 
entity, ADM may be symptomatic or asymptomatic, may progress rapidly or may linger 
for days before causing pain and/or perforation, and resolve spontaneously or need 
treatment with antibiotics. 
The organisms most commonly responsible for these infections are Streptococcus 
Pneumoniae (25 to 50%), Haemophilus Influenza (15 to 30%) and Moraxella Catarrhalis 
(3 to 20%) (Adderson, 1998). It is possible to have several organisms cultured from one 
middle ear, as well as different organisms from the right and the left ear. In addition, 20 
to 30% of cultures show no pathogenic bacteria (Chartrand & Pong, 1998). 
Spontaneous resolution of AOM is very common, most often occurring in 
children older than 2 years, when the TM has not perforated, and in children with no 
underlying anatomical abnormality, immune deficiency, or history of recurrent disease 
(Berman et al. 1987; Conrad, 1998). Several studies have compared the use of antibiotics 
versus placebo in treatment of ADM and found that between 86% and 92% of children 
treated with placebo had resolution of AOM (Chartrand & Pong, 1998; Rosenfeld, 1996). 
Rosenfeld also examined the use of other unconventional treatments of AOM and 
deduced that with the high occurrence of spontaneous resolution, these other therapies 
could also be interpreted as effective treatment without actually providing any real 
therapeutic benefit (1996). 
ADM may resolve on its own or with the assistance of antibiotic therapy. After 
the acute infection has cleared, there is often an associated effusion that may take up to 3 
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months to completely clear (Berman, 1996; Fergie & Purcell, 1998; Kempthome & 
Giebink, 1991; Klein, 1994; Rosenfeld, 1996). The presence of effusion is quite 
common, occurring in approximately 50% of all children diagnosed with ADM. Some 
providers choose to treat the resultant effusion with antibiotic therapy, but this issue is 
controversial and of questionable effectiveness (Dowell et al., 1998; Kempthome & 
Giebink, 1991; Rosenfeld, 1996), The effusion is most often related to the inflammatory 
process associated with the acute infectious process, which is an expected course of 
ADM, for which antibiotics are of no benefit. 
Untreated ADM, Treatment of PADM, and Unresponsive ADM 
Dne of the main arguments for antibiotic treatment of ADM is the reduction in 
risk of suppurative complications. Complications such as meningitis, mastoiditis, chronic 
effusions, and intracranial infections, which were common prior to the introduction of 
antibiotic therapy, have been decreased quite considerably (Bluestone, 1989; Conrad, 
1998; Klein, 1994). In countries other than the United States where antibiotic therapy is 
not used as readily, there have been no studies that have shown that the incidence of 
suppurative complication is higher. In addition, these countries have also seen a 
reduction in the incidence of suppurative complications despite the infrequent use of 
antibiotic treatment (Conrad, 1998). 
PADM after the initial treatment may either be the result of the normal course of 
inflammation after ADM or a persistent infection due to the initial antibiotic not killing 
all the bacteria present. If the cause is determined to be continued infection a course of 
second line antibiotics is usually sufficient to clear the infection (Rosenfeld, 1996). If 
there are no signs or symptoms or infection, the inflammation is allowed to resolve on its 
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own without additional treatment. 
Conductive hearing loss is usually not a problem with isolated cases of ADM but 
rather becomes an issue with otitis media with effusion (DME) that persists greater than 3 
months. This may cause a significant impact on the child's speech, language 
development and developmental process if not identified and addressed early (Fergie & 
Purcell, 1998; Kligman, 1992). Speech and language development should be assessed in 
children who have frequent episodes of ADM as well as those who have effusions that 
persist longer than 3 months (Kligman, 1992). 
ADM may fail to resolve despite the use of antibiotic therapy. One common 
cause of treatment failure is the inability of the antibiotic to effect an optimal middle ear 
concentration to kill the bacteria. Canafax and Giebink (1991) report a study that showed 
the middle ear concentration of antibiotic was only 41 % of that necessary for amoxicillin, 
23% for cefaclor, 27% for sulfamethoxazole, 20% for sulfisoxazole, and 10% for 
erythromycin. As discussed earlier, antibiotic resistance is another increasingly common 
reason for unresponsive AOM. The use of stronger, more potent antibiotics is ultimately 
necessary to treat these types of infections. 
Posttreatment Follow-up Patterns 
Providers generally have recommended that patients return for a follow-up 
examination after completion of treatment to determine if the infection has resolved. The 
timing of this visit has been set at anywhere from 2- to 6- weeks after treatment and 
based on a variety of criteria (Berman, 1996; Bluestone, 1989; Bollag & Bollag-Albrecht, 
1991; Paradise, 1995). Despite the lack of research evidence supporting the necessity of 
this visit, providers have continued to recommend routine follow-up. Recently, however, 
several researchers have defined problems associated with the timing of the follow-up 
visit and have recommended either delaying or omitting the follow-up visit altogether. 
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Despite studies indicating that effusion alone is not a sign of persistent infection, 
many providers mistake this middle ear fluid as a sign of an infectious process and 
choose to administer an additional course of antibiotics. This is usually unnecessary as 
the condition is not infectious but rather proceeding through the normal process of 
resolution and will most often resolve on its own in several months (Dowell et aI., 1998; 
Schwartz et aI., 1987). 
Theoretical Framework 
The theoretical framework to be used for the foundation and guidance of this 
study is Pender's Health Promotion Model. Application of this theory to the assessment 
of the accuracy of parental perception of resolution of infection will assist in 
understanding the knowledge the parents have regarding how symptoms are related to the 
health or illness status of the child. The theory highlighted certain variables that 
influence an individual's understanding of health status and incentive to change current 
health behaviors. 
The underlying assumption of the Health Promotion Model is that the clients must 
take an active role in shaping and maintaining health behaviors and adjusting the 
environmental context of those behaviors when they are able (Pender, 1996). One 
specific assumption is that people have the capacity for self-awareness and are able to 
assess their own competencies. The theoretical model is made up of three sections: 
Individual Characteristics and Experiences, Behavior-Specific Cognition's and Affect, 
and Behavioral Outcome, each having several variables that contribute to the health 
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behavior of an individual (Pender, 1996). In Pender's theory, if an individual feels that 
certain behavior is important to his or her health status, he or she will act on that behavior 
to elicit a specific goal or outcome. In relation to this study, the parent is being given 
information to make an assessment of the health status of the child and therefore can 
impact how the child is subsequently treated. 
Extensive research has been done using this theory as a basis for assessment of 
overall health promoting behaviors as well as specific behaviors such as exercise and 
hearing protection (Pender, 1996). Researchers have analyzed from 5- to 12- of the 
variables at a time and found that certain variables are more predictive than others of 
subsequent health promoting behaviors. Most of the investigators have looked at the 
behavior of a specific individual or group, but the model can be easily used in assessment 
of the health promoting behaviors the parent exhibits while caring for their dependent 
children. Specifically, the individual characteristics of the parent, encompassing their 
prior behavior and personal factors, will impact the behavior-specific cognition and affect 
they exhibit when faced with making decisions about the health care of their child. The 
parent must determine if there are any benefits or barriers to seeking care, the perceived 
self-efficacy of the behavior, and any active related affective responses that must take 
place prior to accomplishing a specific behavior. 
This study examined the ability of parents to make informed assessments of the 
child's health status with the goal of encouraging the parents to seek care only if they felt 
it was necessary. By giving parents the education, knowledge, and reinforcement that 
they are able to accurately assess their child's condition, we are enabling them to take 
more responsibility for their child's health status. The key to the effectiveness of this 
theory in the study is that providers have the ability to influence the behavior-specific 
cognitions and affect of the parent by providing education, information, and the 
reinforcement that the parent is an accurate judge of the health status of the child. This 
concept and theoretical framework will provide the basis for the design and method of 
this study. 
Significance and Rational for the Study 
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The practice of routine follow-up visits (timing and necessity) has a limited 
research basis. The rationale for these visits shows considerable provider variation and 
has been shown to be of limited benefit when the patient is seen while the effusion is still 
resolving. Research by Hathaway et al. (1994) has shown that parents are able to 
identify when their child's AOM has resolved and recommended that follow-up be only 
selectively offered. 
The practice of routine follow-up visits for all patients diagnosed and treated for 
AOM has resulted in increased costs to patients and third-party payors, increased 
invasive procedures, and may have contributed to the increase in antibiotic resistance. 
Additional, stronger courses of antibiotics are often administered for conditions that may 
resolve on their own. Since the literature cannot the support the necessity of this visit, it 
is a practice that must be evaluated and possibly changed. Investigators have already 
identified certain patients and conditions that predispose an individual to complications 
or persistent infections. We must now evaluate the necessity of the follow-up visit for 
those patients who do not exhibit signs or symptoms of persistent infection. 
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Research Questions of the Thesis 
Several answers to questions may offer insight into how much parents understand 
about the etiology of AOM and the symptoms that signify an acute infection versus the 
presence of a persistent effusion. The parents/guardians of the children involved in the 
study have been given written information about the diagnosis and the signs and 
symptoms of AOM. They were then asked to use this information at the follow-up visit 
to make a judgment of whether or not the infection had resolved. The research questions 
are as follows: 
1. What percentage of patients actually return for the recommended routine 
follow-up visit? 
2. Does the parental report of presence or absence of infection agree with the 
presence or absence of PAOM as determined by the provider exam? 
3. What symptoms from the parent's perspective are most commonly associated 
with the presence of AOM after treatment completion? 
Operational Definitions 
For the purposes of this research, specific concepts will be defined to assure 
consistency in evaluation and diagnosis of subjects. As stated in the review of literature 
above, the diagnosis of AOM has certain characteristics that must be met in order to 
accurately state that the patient has AOM. 
AOM Acute otitis media - A bulging tympanic membrane with evidence 
of fluid or air bubbles behind the membrane; opaque, red, or dull in 
color (identified with an otoscope); decreased movement of the 




by symptoms of fever, irritability, pain, vomiting, anorexia, 
diarrhea, purulent discharge, or hearing loss (Altemeier, 1998; 
Bluestone, 1989; Canafax & Giebink, 1991) 
Persistent acute otitis media - An AOM, as defined by the above 
signs and symptoms, that has continued despite treatment with a 
complete course of antibiotics. Usually indicating treatment with 
an alternative course of antibiotics is necessary to effect a cure 
(Rosenfeld, 1996). 
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Otitis media with effusion/serous otitis media - A middle ear 
effusion that has persisted after a complete course of treatment 
with antibiotics. Effusion is determined by presence of clear or 
colored fluid visible behind the TM and decreased or absent 
mobility of the TM. This may be present for several months after 
treatment for AOM or may be unrelated to an episode of AOM 
(Bluestone, 1989). 
Unresponsive acute otitis media - An AOM, as indicated by the 
continued signs and symptoms of the initial presentation, that did 
not begin to resolve in 24 to 48 hours after the initial course of 
antibiotics was initiated, usually necessitating a change in the 




A prospective design was used in this study, focusing on the association between 
parental impression of resolution of AOM in the child and the diagnostic impression of 
the provider. The child and his or her parent(s) were seen at initial diagnosis of AOM 
and again at the follow-up visit 14 to 21 days after diagnosis of AOM. Data were 
collected at the follow-up visit after the parent has agreed to participate in the study. 
Setting 
Hill Air Force Base Pediatric Clinic is a multiservice Pediatric Clinic offering 
services that include well baby and child care, physical examinations, acute illness care, 
routine visits for any nonacute type complaint, chronic disease management and 
evaluation for referral to subspecialty clinics. One board-certified pediatrician and two 
certified pediatric nurse practitioners as well as three medical technicians and one 
registered nurse staff the clinic. Most appointments are made through an appointment 
line staffed with clerks who schedule appointments for all clinics in the facility, with the 
exception of follow-up appointments which are scheduled by the Pediatric Clinic staff 
within the time frame requested by the provider. 
The clinic outpatient records department maintains the patient records. Patient 
charts are obtained from this department by the clinic staff or the patients prior to the 
scheduled appointment. Labs, radiographs, and prescriptions are all ordered by the 
provider via the computer with the data related to ordering and prescribing available in 
the computer database. Occasionally, previous records are unavailable at the scheduled 
visit due to being lost or a recent transfer to this base. 
Sample 
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A convenience sample of patients presenting to the Pediatric Clinic of Hill Air 
Force Base (AFB) and diagnosed with AOM were asked to participate in the study. Sixty 
patients between the ages of 6 months and 12 years were included in the study. The 
length of the study was 3 months and was begun after approval from the IRB at the 
University of Utah and the Hill AFB Clinic. Exclusion criteria included: the presence of 
pressure equalization tubes (PET), AOM within 1 month of this episode, 
immunocompromised status, anatomic abnormalities of the ear canal or upper respiratory 
system, other associated illnesses requiring antibiotics, use of antibiotic prophylaxis, and 
the inability of the parent to read or comprehend English. 
Instruments 
The AOM Information and Instructions form (Appendix A) was given to the 
parent by the provider after the child was diagnosed with an AOM and the parent had 
agreed to participate in the study. The form contained information including the name of 
the antibiotic the child had been prescribed, signs and symptoms of an ear infection, and 
when to call the clinic if the symptoms were not resolving. The date and time of the 
scheduled follow-up appointment were added to this form after the appointment was 
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made by the office staff and confirmed with the parent. 
The Patient Log form (Appendix B) was used as a means of keeping track of 
patients accepted into the study. The form consisted of four columns in which to record 
the patient name and identification number, the date of the diagnosis, the date scheduled 
for the follow-up visit and the provider who saw the patient. 
The Study Information Sheet/Consent (Appendix C) provided information on the 
name and purpose of the study. It also provided information on the process that took 
place when the parent chose to participate in the study. In the form, parents were given 
the name of the researcher and phone numbers to obtain more information or have any 
questions answered. This form included a place for the parent and researcher signatures, 
which, when signed, served as the agreement to participate in the study. The researcher 
and the parent both kept a copy of this form. 
The Follow-up Visit Questionnaire form (Appendix D) was completed by the 
parent when he or she presented for the follow-up visit. The questionnaire contained a list 
of 10 symptoms that the child could be experiencing at present. Marks were made next 
to the symptom or symptoms that the child was experiencing at that time. If the child had 
no symptoms, that space on the form was marked. After these symptoms were listed, the 
parent was asked seven questions regarding whether or not he or she felt the infection had 
cleared up, what antibiotic the child was on, whether the child took the medication as 
ordered, how long the child had symptoms after starting treatment, any history of 
recurrent ear infections, and if the child had been seen by any provider since the 
diagnosis of AOM. 
The Follow-up Visit Provider Exam form (Appendix E) was completed by the 
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provider after the child was examined. Notation in this section included the color of the 
TM, mobility, presence of fluid or air bubbles, presence of PET, and if the TM was not 
visualized. The provider also noted if the exam was normal, or if there was evidence of 
continued infection or other disease. This form included an area for a pictorial 
description of the appearance of the TM. At the bottom of this part of the form was a 
statement asking if there was concurrence between the parental perception and the 
provider exam. The researcher completed this statement. 
This form was pretested on 10 patients and parents to determine ease of use and 
effectiveness of data collection. No changes or clarifications were needed after this 
initial pretesting. Content utilized in construction was based on information obtained in 
the literature review pertaining to signs and symptoms of AOM, essential elements of the 
provider exam, and history and demographic information. 
The Ear Recheck Form (Appendix F), which was used for all patients being seen 
for follow-up after an AOM, was also completed when the patient was examined by the 
provider. This form was placed in the chart as a permanent part of the patient's record. 
The Follow-up Visit Questionnaire and Follow-up Visit Provider Exam forms 
(Appendix D and E) were the only forms to be utilized for data collection. The Patient 
Log form (Appendix B) was only for the convenience of the researcher and the clinic 
staff. Appendix A and C forms were used to give information on the diagnosis, signs and 
symptoms, medication, and follow-up visits and to obtain informed consent for 
participation in the study. These forms were essential to ensure consistent information 
was disseminated to all study participants. They also provided a means for parents to 
review the signs and symptoms of AOM, the normal course of infection resolution, and to 
assist them in determining when an earlier return visit would be necessary. 
Procedure 
Approval for the study was obtained from the IRB of the University of Utah as 
well as the IRB at Hill AFB Clinic. Upon approval of the study, an in service was 
provided to all Pediatric Clinic staff and providers which familiarized them with the 
study and the tools that were used to collect the data. 
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Providers were responsible for making the diagnosis of AOM and asking the 
parent of the patient if they would like to participate in the study. Diagnosis of AOM was 
made based on clinical objective assessment of the TM and middle ear with pneumatic 
otoscopy, along with the subjective report of signs and symptoms. The provider then 
chose the appropriate antibiotic and instructed the parents on medication use and when to 
return to the clinic for follow-up. The signs and symptoms of AOM were reviewed with 
the patient and parents at this time. Any parent of a patient diagnosed with AOM who 
met the study criteria was asked to participate in the study. The Acute Otitis Media 
Information and Instruction form (Appendix A) was reviewed and given to the parents 
prior to leaving the providers office. 
Clinic staff made follow-up appointments for the patients in the time frame of 14-
to 21- days from the date of diagnosis and noted the date and time on the AOM 
Information and Instruction Sheet (Appendix A). The log of patients in the study was 
kept at the front desk of the clinic (Appendix B). This log enabled me and clinic 
personnel to keep track of the patients in the study and to contact them if they failed to 
make the follow-up appointment. Two copies of the Study Information Sheet/Consent 
(Appendix C) detailing the objectives of the study were given to the parents after they 
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agreed to participate. One copy was signed by the parent and a witness, and kept by the 
researcher, and the other copy was given to the parent for reference. 
At the follow-up visit, the parent was asked to complete the Follow-up Visit 
Questionnaire (Appendix D) about the child's current symptoms and their perception of 
whether or not the infection had resolved. The provider did not view the completed 
Follow-up Visit Questionnaire form (Appendix D) prior to performing the pneumatic 
otoscopy exam on the child. This ensured that the provider was not influenced by the 
parental report. After the exam, the provider used the Follow-up Visit Provider Exam 
form (Appendix E) to annotate the appearance and mobility of the TM as well as the 
results of the exam as normal, infection (BOM, ROM, LOM), or effusion (OME, SOM). 
Documentation of the visit was also recorded on the standard ear recheck form currently 
used in the Pediatric Clinic (Appendix F) and placed in the patient's chart. 
After the parent and the provider had completed the above forms, they were given 
to the researcher who noted whether or not there was concurrence between the parental 
assessment of presence of infection and the objective exam by the provider. This was 
noted at the bottom of the Follow-up Visit Provider Exam form (Appendix E). 
Data Analysis 
Data from the questionnaire were quantitative. These data were analyzed using 
software from the Statistical Package for the Social Sciences (SPSS), including frequency 
distributions, Kappa, and Fisher's Exact Test. The alpha was set at .05 to determine 
significant relationships. Frequencies including central tendencies and variability were 
computed for the demographic data. Kappa was used to measure the agreement between 
the parental and providers report of presence or absence of infection. Fisher's Exact Test 
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was used to calculate the relationship between the symptoms reported by the parents and 




The characteristics of the sample and the results of the data analysis are presented 
in this chapter. The analyses are introduced as they relate to the research questions of the 
thesis. For all inferential statistics, the alpha was set at .05. There were no missing data. 
Sample 
Eighty-two parents of patients diagnosed with AOM at the Hill AFB Pediatric 
Clinic were entered in to the study. Sixty of these individuals returned for the follow-up 
exam, completed the questionnaire and were examined by a provider. The information 
from these 60 patients was utilized in the evaluation of the data. 
Characteristics of the Sample 
The parents of the children who were diagnosed with AOM were the actual 
subjects of the study, but information about the children is integral to an analysis of the 
sample and will be detailed here. The age range of the sample spanned from 6 months to 
12 years, with a mean of 2.9 years, a mode of 2.0 years and a median of 2.0 years. The 
majority (58%) of the children were 2 years old and younger. Other demographic data 
gathered in the questionnaire included the type of antibiotic the patient was prescribed 
(65% Amoxicillin), the compliance for that antibiotic (98% compliant), number of days 
the patient had symptoms of AOM (90% less than 4 days), family history and personal 
history of AOM (see Table 1). 
Research Question One 
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The first research question was to determine the percentage of patients that return 
for the scheduled follow-up visit. This question was easily answered by utilizing the 
patient log and counting the number of patients entered into the study by the providers 
and then counting the number of the patients who had completed questionnaires. The 
total number of subjects entered into the study was 82, of which 60 returned for the 
follow-up examination, resulting in a return rate of 73%. 
Of the 22 patients who did not return for the follow-up visit, 20 were contacted to 
determine the reason they did not return for the visit. One was not contacted due to the 
family leaving the area and the other patient did not return messages that were left at the 
home. Eighteen of the 20 parents stated that the child was better and they felt it was 
unnecessary to return for the follow-up. Of the two other children who did not return, 
one had an appointment scheduled with a specialty provider, and one had been seen at a 
local emergency room for another reason and thought that the child did not need to be 
seen again. 
Research Question Two 
The second research question addressed the agreement between the parental 
report and the provider exam. On the questionnaire, the parent was asked if he or she felt 
the infection had cleared up. After examining the child, the provider also noted if the 
exam was normal, if there was presence of OME, SOM, or infection. The researcher then 
Table 1 
Demographic Data of Patients Diagnosed with AOM who returned for Fol1ow-Up 
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analyzed the responses and noted if there was concurrence between the two evaluations. 
In 54 cases there was agreement between the parental report of no infection and 
provider exam identifying absence of infection; six cases did not show agreement, 
resulting in an agreement value of 90%. The agreement between these two evaluations 
was analyzed by kappa, which measured the agreement between the evaluations of two 
raters when those two raters are evaluating the same item (the child). Using the kappa 
coefficient, which corrects for chance agreement between observers, the results identified 
a significant kappa value of -.209 <R < .0001) indicating that there is good interobserver 
agreement on presence or absence of PAOM (see Table 2). 
Two children were thought by the parents to have no infection present but were 
found to have an infection present upon examination by the provider. Further evaluation 
of the demographic data of these two children showed that they were both males, 15 and 
16 months old, with a personal or family history of AOM. They had both been given 
amoxicillin and had symptom resolution in 2 to 3 days after the antibiotic was started, but 
presented to the follow-up appointment with only the symptoms of cough/runny nose 
reported. 
Research Question Three 
"What symptoms were most commonly associated with the presence of AOM 
from the parents perspective after the completion of treatment?" was the third research 
question to be answered. Fisher's exact test was used to assess the significance of the 
relationship between the symptoms reported by the parent when the parent also reported 
that they felt the infection was still present. Of the 11 choices the parent had when 
stating what, if any, symptoms were present in the child, 7 were used in the analysis of 
Table 2 
Results of Agreement between Parental Report of Infection and Provider Determination 
of Presence or Absence of Infection ill = 60) 
Parental Assessment 
Presence of Infection 
K= -.209 
No 
o/c of total 
Yes 



























significance. Four were not used for analysis since they were not used by the parents: 
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vomitting, ear drainage, other symptoms, and other choice being "no symptoms." Of the 
seven symptoms reported, the only two responses that showed significant association 
with the actual presence of infection as perceived by the parent and validated by the 
provider exam were pulling at ears <n = .004) and complaint of earache <n = .013) (see 
Table 3). 
Similar analysis was done for the relationship between the symptoms reported by 
the parent and the results of the provider exam. The providers were not specifically 
examining the child's symptoms, only the objective assessment of the TM with 
pneumatic otoscopy, but the relationship between the reported symptoms and the 
Table 3 
Fisher's Exact Results of Comparison of Parental Reported Symptoms and Parental 
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presence of infection is important to understand. Of the eight symptoms reported, the 
two responses that showed significant association with the actual presence of infection 
were fever (12 = .043) and cough (12 = .007) (see Table 4). 
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At least one type of symptom was reported for 37 of the 60 subjects, but only 10 
of the parents felt that the symptom(s) were indicative of persistent infection. Of the two 
subjects where the parent reported no infection and the provider found infection still 
present, the reported symptoms in both subjects were cough/runny nose. 
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Table 4 
Fisher's Exact Results of Comparison of Parental Reported Symptoms and Provider 
Reported Presence of Infection (n.. = 60) 
Infection No Infection 
Symptom n % n % 
1. Fever 0.043 
Yes 3 37% 4 8% 
No 5 63% 48 92% 
2. Fussy/Sleep Problems 0.12 
Yes 3 38% 7 13% 
No 5 62% 45 87% 
3. Poor feeding 0.593 
Yes 1 13% 5 10% 
No 7 82% 47 90% 
4. Diarrhea 0.867 
Yes 0 0% 1 2% 
No 8 100% 51 98% 
5. Cough 0.007 
Yes 7 88% 18 35% 
No 1 12% 34 65% 
6. Pulling at Ears 0.09 
Yes 3 37% 6 11% 
No 5 63% 46 89% 
7. Earache 0.555 
Yes 0 0% 4 8% 
No 8 100% 48 92% 
8. Other Symptoms 
Yes 0 0% 3 60/0 0.646 
No 8 100% 49 94% 
CHAPTER V 
DISCUSSION 
In this chapter, a discussion of the results that were presented in Chapter IV is 
provided. The research design is examined and discussed. A brief discussion of the 
usual pattern of care for patients diagnosed with AOM at the Pediatric Clinic of Hill AFB 
is provided, along with plans for a change in that protocol based on the results of this 
study. The results are examined, with particular attention to the compliance with the 
recommended follow-up, the report of symptoms present, and the agreement between 
parental perception and provider examination. Possible explanations for the findings are 
explored next. Finally, a discussion of implications for nursing, clinical practice, 
education, and the recommendations for future research are addressed. Limitations of the 
study are also addressed in this review. 
Design 
This research study used a nonexperimental, prospective, descriptive design. 
Only subjects that were diagnosed with AOM and met the study criteria were asked to 
participate in the study, therefore there was no manipulation of the independent variable, 
control group or randomization of the subjects necessary. The goal of the study was to 
ascertain whether or not the parents were able to accurately assess their child for the 
presence of a PAOM at the time of the follow-up visit. This assessment by the parent 
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was compared to the objective examination of the TM as done by the provider, blind to 
the parental assessment, which was considered the "gold standard." A prospective, 
descriptive design was appropriate for this purpose. Despite the fact that the study was 
accomplished in a military facility where cost of visits and medications were not a factor 
for the parents, the results can be generalized to any population in which a managed care 
organization or other payor has a desire to eliminate unnecessary visits and reduce costs. 
One limitation to the study and the results is the instrument used for the data 
collection. This tool was developed by the researcher for the purpose of this study; 
therefore, the reliability and validity has not been established. The straightforward 
objective nature of the data argue for face validity. Parents did have the opportunity to 
ask the clinic staff for clarification of questions while completing the questionnaire, but 
there is the potential that parents could have misunderstood the instructions and thus 
completed the form incorrectly. During pretesting, attention was paid to the ease of use 
and readability, and there were no problems found. There were no missing data in the 
study, which strengthens the results and conclusions. 
The sample was homogeneous as members of the military and dependents. All 
children had been diagnosed with AOM in this facility and in most instances, were 
scheduled follow-up visits with the same provider that had diagnosed the initial infection. 
The small number of clinic personnel assisted in maintaining a consistency of 
information given to the parent and an assurance that identical criteria was used for the 
diagnosis of AOM at initial and follow-up visits. This level of control is ideal and cannot 
be assumed that would be similar in other facilities of different sizes or with a more 
diverse population. 
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Usual Care Pattern 
In order to put the results and discussion of them into perspective, an 
understanding of the usual pattern of care and follow-up in this Pediatric Clinic must be 
had, as well as the magnitude of this patient population. When a child is diagnosed with 
an ADM, the parent is given instructions on use of the medication, signs and symptoms 
to watch for that would signify the infection was not resolving, and is told to have the 
child seen again in 2 to 3 weeks to see if the infection has cleared up. The parent must 
then call the appointment line and make a follow-up appointment for the child. 
Statistics are not kept on the number of patients diagnosed with ADM who 
subsequently return for follow-up exam so the number can only be inferred by the 
number of children diagnosed with ADM and the number of brief appointments (forear 
recheck only) available. Approximately 4000 children are diagnosed with ADM each 
year in this Pediatric Clinic. There are only approximately 1500 brief appointments 
available each year, of which many often go unfilled. Some parents may also use an 
acute or routine appointment to have an ear recheck performed but this is generally not 
allowed as acute appointments are reserved for acute, new onset problems and routines 
are for problems lasting greater than 3 days. It can be inferred from this data that less 
than half of the children diagnosed with ADM are returning for the recommended follow-
up exam. In this study, 73% returned for the follow-up visit, which was a much greater 
percentage than the general patient population. Despite this lack of follow-up in the 
general clinic population, there have been no incidences of suppurative complications or 
increased incidence of persistent DME with associated speech delays identified in this 
clinic population. For those children who do have frequent, recurrent ADM (> 6/year) or 
have persistent OME for> 3 months, referral to an in-house Ear, Nose, Throat (ENT) 
specialist is provided. 
Possible Explanations 
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As stated in this thesis under "theoretical framework," it was shown that people 
have the capacity for self-awareness and are able to judge their own competency in 
making health related decisions. In addition, it was shown that individuals will act on a 
belief if they feel it is important to the status of their health. This was evident in this 
study as the number of parents who brought the child in for the follow-up exam. Of the 
22 parents who did not return, 18 made the decision to not return based on their own 
assumptions of the health status of their child. Of the 60 who did return for the follow-up 
visit, 54 were correct in their determination of the infection status of the child. 
Combined, this results in a 90% accuracy by the parents in determining presence or 
absence of infection. These results reinforce the understanding that education provided 
to the parents, as well as validation of their ability to make an accurate assessment of the 
health status of their child will increase their ability to continue this behavior in the 
future. 
As stated earlier, 73% of the study participants returned for the follow-up exam. 
Several explanations are possible for this being significantly greater than the general 
population of the pediatric clinic. The parents knew they were part of a study and wanted 
to participate fully, thus returning for the visit even knowing that their child was feeling 
better. Also, having the parent make the follow-up appointment at the clinic before 
leaving, writing down the date and time of the appointment, and giving them written 
information about the study took away the possibility that they would not follow through 
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on making the appointment by phone through the appointment line. Due to the nature of 
the location and population of this study, these results cannot be interpreted as indicative 
of what other studies of similar type may experience. 
This study confirmed the results of the study by Hathaway et al. (1994) which 
found that parents were accurate 97.1 % of the time in determining that there was no 
infection present. Most parents are intimately aware of changes in their child's affect, 
activity level, and mannerisms. Health professionals are more inclined to desire some 
sort of objective assessment to determine what is going on with the patient. This study 
validated the fact that parents, without a means to objectively assess the middle ear of the 
child, were quite accurate in making a determination by subjective means. Looking at the 
results of these two studies, one is led to reconsider the necessity of the follow-up visit 
for most cases of AOM. 
Research question number three was about whether symptoms noted by the 
parents were indicative of a PAOM as noted by the provider. Symptoms were noted by 
37 of the 60 parents (62%), while only 10 (17%) of those parents felt that the symptoms 
were indicative of infection. Of those 10 parents who felt the child had P AOM, 6 were in 
agreement with the provider. The most commonly identified symptoms for these six 
children were cough/runny nose (4) and pulling at ears (4). As identified in the results 
section, the two symptoms that were significantly associated with PAOM from the 
parental perception were pulling at ears and a complaint of earache. One parent reported 
no symptoms but felt the infection was still present, which was confirmed in the exam by 
the provider. Interestingly, pulling at ears was significantly associated with PAOM from 
both the parental report and the provider exam. In the literature review, pulling at ears 
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was dismissed as not a good indicator of AOM and was more often associated with the 
presence of teething pain in the infant and child. This result may be unique to this study 
population or may be reflective of the ages of the children with the majority (58%) being 
2 years old and younger. This age group generally has limited verbal skills, which may 
lead the parents to rely on more obvious symptoms such as pulling at the ears, cough, 
runny nose and increased irritability rather than the child telling the parent that they have 
ear pain or they cannot hear as well. 
Several of the Follow-up Visit Questionnaires had comments such as ''just started 
today" written next to the symptoms which were not used in the data analysis but gave 
insight into the number of reported symptoms. The questionnaire asked what symptoms 
the child was experiencing at present as well as how many days the child had symptoms 
after starting the antibiotics. The majority (90%) of the days reported for continuing 
symptoms was four or less. These data show that the symptoms of the initial infection 
had resolved with the initial treatment, but now new symptoms had arisen. These new 
symptoms may be a new infection starting or may have been unrelated to the presence of 
an infection. 
The provider has the opportunity, at the time of diagnosis of AOM, to determine 
what symptoms the parent identified in the child, what caused the parent to determine 
that the child needed to be examined, and also the parent's level of comfort in evaluating 
the needs of their child. The provider also has the opportunity to provide further 
education to the parent who may not know what signs or symptoms may indicate a new 
or persistent infection. In this study, many of the signs and symptoms of AOM were 
listed on the information sheet that was given to the parent after the child was diagnosed 
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with AOM. This may have influenced the parent's ability to look for and identify those 
symptoms in the child. 
Implications for Nursing 
The explanation in the previous section creates important implications for 
nursing, especially in terms of the role of the Pediatric Nurse Practitioner. 
Clinical Practice 
The results suggest that parents are already making the decision themselves about 
whether or not to bring the child in for follow-up. Therefore, it is essential that the 
provider give accurate information about the signs and symptoms of A OM to the parent 
at the time of diagnosis. The parent must then be instructed to return to the clinic for 
reevaluation of the child if they identify any of the signs or symptoms. The signs and 
symptoms reported by the parents can be quite varied and may have no relationship to the 
presence of infection in that particular child. The provider must then educate the parent 
on identification of what symptoms the child was exhibiting prior to the diagnosis of 
AOM, and to watch for the persistence or reoccurrence of those symptoms. 
The process of instructing every patient diagnosed with AOM to return for 
follow-up is also not necessary. A majority of these patients are not returning and the 
parents are able to accurately identify whether the infection has cleared or is persisting. 
This visit needs to be selectively offered to those children whose parents feel the 
infection has not resolved, cannot accurately identify the symptoms, or if they have a 
history of AOM or persistent OME (Hathawayet al., 1994). By eliminating or revising 
this process, we are making more appointments available for other acute or routine needs. 
The time spent by the provider in educating the parent will be well spent when the only 
children brought in for the follow-up visit are those that truly need to be seen. 
Education 
The education of nurses and other medical personnel often focuses on 
understanding the physiology of disease and subsequent treatment. The results of this 
study validate the need for assessing the symptoms of the presenting illness, listening to 
the subjective assessment of the parent and patient, and thoroughly educating the parent 
on the signs, symptoms, and disease process. 
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As Pender (1996) noted in her Health Promotion Model, people will act on the 
information they have to make decisions about specific health behaviors. The education 
that nurses and other health care providers receive must include techniques in the 
assessment of caregiver knowledge and their ability to apply that knowledge for the 
benefit of the child. Much time is currently spent educating health care personnel in the 
assessment and treatment of specific disease, additional time must be spent in ensuring 
that providers understand the importance and necessity of teaching and listening to the 
patient. 
Future Research 
Future studies should look at the patterns of care, complications, and 
consequences once the follow-up visit recommendation is eliminated. First, after 
implementation of the protocol that all patients will not be asked to return for follow-up, 
a study should be done to determine the percentage of parents who still choose to bring 
the child back in for a recheck. By evaluating this, as well as the parent's reason for 
43 
bringing the child in, we will be better able to tailor our education to the needs of the 
patient population. Second, after routine follow-up visits have been eliminated, a study 
should be done to assess for any increase in the incidence of suppurative complications or 
OME that goes undetected after an episode of AOM. Persistent OME in the preverbal 
population is a significant concern and any increase in this incidence would need to be 
acted upon. 
This research study was conducted in a very select group of individuals. The 
follow-up rate, compliance with medication, and the availability of free medical care, 
consultations, and medications may have influenced the significance of the outcome. To 
generalize outside of this group on the basis of this research alone would not be 
recommended. Using the results of the research that has already been done, along with 
the results of this research, however, would increase the credibility and validity of 
making changes in the current practice of AOM follow-up. 
Summary Statement 
Despite the limitations of this study, important information was gathered. The 
percentage of patients returning for the follow-up visit was larger than expected, as 
compared to previous studies and in the general population of the pediatric clinic. The 
agreement between the parental perception of infection and the presence of infection as 
determined by the objective exam of the provider was found to be significant, which was 
the result that had been anticipated. The parental report of symptoms was perhaps the 
most confusing of the data, as the symptoms that were significantly associated with 
parental report of infection, and validated by the provider exam, were those that were not 
deemed significant predictors in previous studies. 
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Implications for nursing from this study include the suggestion that the routine 
follow-up visit for AOM is eliminated and selectively offered to those children who are at 
highest risk for persistence and/or complications. In addition, increasing the amount of 
education provided to the parents, along with validation of the accuracy of their 
perception of the child's health status, will increase the ability of the parents to become 
even better advocates for their child's health. Future research of similar type in other 
settings and research on compliance and complications once the follow-up visit is 
eliminated is also necessary. 
Addressing the problem of how best to serve our patients without over or 
undertreating, and still maintaining access to the pediatric clinic, is an ongoing challenge. 
Evaluating practices that have been adopted as standard of care, but perhaps are no longer 
appropriate is one way to address this issue. As costs of health care continue to rise and 
individuals are asked to take greater control of their own health care needs, our jobs as 
health care providers will be challenged and must be adapted. It is imperative that we 
offer education and information to patients and families to better equip them to meet 
these increased demands. 
APPENDIX A 
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Acute Otitis Media Information and Instructions 
l. Your child has been diagnosed with an ear infection (acute otitis media) and 
prescribed an antibiotic to treat the infection. The antibiotic is _____ _ 
please take all the medication as prescribed and instructed by your provider. 
2. Signs and symptoms of an ear infection are: fever, fussiness, irritability, poor feeding, 
vomiting, diarrhea, tugging at ear, decreased appetite, complaint of ear pain, drainage 
from the ear, or hearing loss. 
3 . Your child may still have signs or symptoms for 24 to 48 hours after starting the 
medication. If symptoms last longer than this time, make an appointment for the 
child to be seen in the clinic. 
4. A follow-up appointment is scheduled for _____ _ Your child's ears will 






STUDY INFORMATION SHEET/CONSENT 
Study Information SheeUConsent 
Necessity of Routine Follow-up Visits after Diagnosis of Acute Otitis Media: A 
Comparison of Parental Report of SymptonlS and Presence or Absence of Actual 
Persistent Infection 
Julie Resheske-Fisher, RN, Principal Investigator 801-771-1907 (24 hr number) 
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Background: You are invited to participate in a study designed to examine how well 
parents can assess their child's symptoms and determine if the ear infection has cleared 
up. The purpose of this study is to determine if the parental report of the presence or 
absence of symptoms of an ear infection at the follow-up visit is an accurate indicator of 
the actual presence or absence of an infection as determined by an objective exam from 
the health care provider. 
Study Procedures: If you decide to participate in the study, please sign this consent 
form and return it to your health care provider. Your child will be scheduled a follow-up 
visit in 14 to 21 days to re-examine hislher ears. At the follow-up visit, you will be asked 
to complete a short questionnaire asking what, if any, signs and symptoms of an ear 
infection your child has. You will also be asked if you feel the infection has or has not 
cleared up. 
Risks: No significant risks are anticipated as a result of your participation in this study. 
Benefits: The information provided as a result of this study will help us to understand 
what signs and symptoms are most predictive of a persistent ear infection as well as how 
accurate parents are in assessing whether or not the child's ear infection has cleared up. 
There is no compensation for participating in this study. 
Alternative Procedures: You may choose not to participate in this study. If you choose 
not to participate, this will not affect your relationship with your child's health care 
provider, the clinic, or the medical care your child receives. 
Confidentiality: All information provided to the researcher will be kept strictly 
confidential. All questionnaires and forms will be kept locked and will be destroyed 
upon completion of the study. 
Ouestions and Contact Person: I will answer any questions you may have concerning 
the study. You may contact me at 801-771-1907 (24 hr telephone number) or at 801-777-
6214 during the normal duty day. If I am not there, please leave a message and I will 
contact you as soon as possible. 
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Institutional Review Board: If you have questions regarding your rights as a research 
subject, or if problems arise which you do not feel you can discuss with the Investigator, 
please contact the Institutional Review Board Office at 801-581-3655. 
Medical Treatment or Compensation for Injury: In the event you sustain injury 
resulting from your participation in the research project, the University of Utah can 
provide to you, without charge, emergency and temporary medical treatment not 
otherwise covered by your own insurance. If you believe that you have sustained an 
injury as a result of your participation in this research program, please contact the Office 
of the Vice President for Research, telephone nUITlber 801-581-7236. By signing this 
document you are not giving up your right to pursue legal action against any and all 
parties involved with this research, in accordance with the Utah Governmental Immunity 
Act, Section 63-30-1 :63-30-34 Utah Code Ann. 1953 (as amended). 
Voluntary Participation: Your participation in this study is completely voluntary. If 
you do not wish to participate, the care your child receives will not change. You may 
chose to stop participating in the study at any time. 
Unforseeable Risks: Although there are no significant risks anticipated as a result of 
your participation in this study, unforseeable risks may occur. 
Right of Investigator to Withdraw Subiect: If during the course of the study you no 
longer meet the inclusion criteria, the investigator may decide to stop your participation 
in the study without asking you. 
Costs to SUbjects: There will be no cost to you or your insurance company for your 
participation in this study. 
New Information: Any significant new findings discovered during this research study 
that may influence your willingness to participate in this study, will be made known to 
you. 
Number of SUbjects: Approximately 100 families will be invited to participate in this 
research study. 
Consent 
I have read the above information and my questions have been answered. I desire to 
participate in this study and accept the benefits and risks. I understand that a copy of this 
consent document will be given to me. 
Signature of Research Participant Date 
Witness Date 
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53 
Date: ___ Patient Name: ________ Last 4 of SSN: __ Age: __ 
Provider: ________ _ 
Parents fill out this section: 
Please place a check by each symptom that your child is experiencing at present: 
1. Fever 7. Other symptoms 
2. Fussy/Sleep problems 8. Pulling at Ears 
3. Poor feeding 9. Earache 
4. Vomiting 10. Ear drainage 
5. Diarrhea 11. No Symptoms 
6. Cough, runny nose 
Do you think the infection has cleared up? YES __ _ NO __ _ 
What antibiotic was the child on? ______ _ 
Did the child take all of the medication as ordered ? _____ _ 
How many days did your child have symptoms after starting antibiotic 
treatment, ___ _ 
Does the child have a history of recurrent ear infections? YES NO __ _ 
Is there a family history of recurrent ear infections? YES NO __ _ 
Has the child been seen by any health care provider since diagnosed with the ear 
infection? ____ If yes, where and 
Thank you for your time !! 
APPENDIXE 
FOLLOW-UP VISIT PROVIDER EXAM 







Shiny __ Dull__ Bulging'--__ AirlFluid Level __ Perforation 
Not Visualized ___ PET present __ _ 







Shiny __ Dull __ Bulging ___ AirlFluid Level __ Perforation 
Not Visualized. ___ PET present. __ _ 
Normal Exam. __ _ 
BOM. ____ LOM ____ ROM ____ SOM ____ OMrn __ __ 
Concurrence with parental report YES NO __ _ 
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APPENDIXF 
EAR RECHECK FORM 





Earpain R L 
Fever 
TM-right- gray, pink, red 
Shiny, dull, air/fluid level 
ago. On d_of 10 of __ _ 
Not Visualized 
Mobile, decreased mobility, immobile 
TM-Ieft- gray, pink, red 
Shiny, dull, air/fluid level 
Mobile, decreased mobility, immobile 
PET: R PET: patent, draining, blocked, in canal 
L PET: patent, draining, blocked, in canal 






Adderson, E.E. (1998). Preventing otitis media: Medical approaches. Pediatric 
Annals, 27(2), 101-107. 
Altemeier, W.A. (1998). A pediatrician's view: Earaches. Pediatric Annals, 
27(2), 62-64. 
Berman, S. (1996). Pediatric decision making (3rd Edition). S1. Louis: Mosby 
Publishers. 
Berman, S., Byrns, P.J., Bondy, J., Smith, PJ., & Lezotte, D. (1997). Otitis 
media-related antibiotic prescribing patterns, outcomes, and expenditures in a pediatric 
medicaid population. Pediatrics, 100(4), 585-592. 
Block, S. L. (1997). Causative pathogens, antibiotic resistance and therapeutic 
considerations in acute otitis media. Pediatric Infectious Disease Journal, 16,449-456. 
Bluestone, C.D. (1989), Modem management of otitis media. Pediatric Clinics 
of North America, 36(6), 1371-1387. 
Bollag, D., & Bollag-Albrecht, E. (1991). Recommendations derived from 
practice audit for the treatment of acute otitis media. Lancet, 338, 96-99. 
59 
Burke, P., Bain, J., Robinson, D., & Dunleavey, J. (1991). Acute red ear in 
children: controlled trial of non-antibiotic treatment in general practice. British Medical 
Journal, 303, 558-562. 
Canafax, D.M., & Giebink, G.S. (1991). Clinical and pharmacokinetic basis for 
the antimicrobial treatment of acute otitis media. Otolaryngologic Clinics of North 
America, 24(4), 859-875. 
Chartrand, S.A., & Pong, A. (1998). Acute otitis media of the 1990's: The 
impact of antibiotic resistance. Pediatric Annals, 27(2), 86-95. 
Conrad, D.A. (1998). Should otitis media ever be treated with antibiotics? 
Pediatric Annals, 27(2), 66-74. 
Daly, K.A. (1991). Epidemiology of otitis media. Otolaryngologic Clinics of 
North America, 24(4), 775-786. 
Dowell, S.F., Marcy, S.M., Phillips, W.R., Gerber, M.A., & Schwartz, B. (1998). 
Otitis media-Principles of judicious use of antimicrobial agents. Pediatrics, 
9(Supplement), 165-171. 
Fergie, J .E., & Purcell, K. (1998). The role of inflammatory mediators and anti-
inflammatory drugs in otitis media. Pediatric Annals, 27(2), 76-81. 
60 
Hathaway, TJ., Katz, H.P., Dershewitz, R.A., & Marx, T.J. (1994). Acute otitis 
media: Who needs posttreatment follow-up? Pediatrics, 94(2), 143-147. 
Jordan, M.J. (1991). Clinical approach to treatment of otitis media. 
Otolaryngologic Clinics of North America, 24(4), 901-904. 
Kempthorne, J., & Giebink, S. (1991). Pediatric approach to the diagnosis and 
management of otitis media. Otolaryngologic Clinics of North America, 24(4), 905-929. 
Klein, J.O. (1994). Otitis media. Clinical Infectious Diseases, 19,823-33. 
Kligman, E.W. (1992). Treatment of otitis media. American Family Physician, 
45(1), 242-250. 
McCraig, L.F., & Hughes, J.M. (1995). Trends in antimicrobial drug prescribing 
among office-based physicians in the United States. Journal of the American Medical 
Association, 273(3), 214-219. 
Paradise, J .L. (1995). Managing otitis media: A time for change. Pediatrics, 7, 
712-715. 
Paradise, J .L. (1995). Treatment guidelines for otitis media: the need for breadth 
and flexibility. Pediatric Infectious Disease Journal, 14(5),429-435. 
Pender, N.J. & Pender, A.R. (1996). Health promotion in nursing practice (3rd 
Edition). Norwalk, CT: Appleton & Lange Publishers. 
Rosenfeld, R.M. (1995). What to expect from medical treatment of otitis media. 
Pediatric Infectious Disease Journal, 14(9), 731-737. 
Rosenfeld, R.M. (1996). An evidence-based approach to treating otitis media. 
Pediatric Clinics of North America, 43(6), 1165-1181. 
Schwartz, R.H., Rodriquez, W.J., Hayden, G.F., & Grundfast, K.M. (1987). The 
reevaluation visit for acute otitis media. The Journal of Family Practice, 24(2), 145-148. 
